Lipoedema & ‘GLP-1s’
Introduction Lipoedema and ‘GLP-1s’ are being discussed much more frequently, particularly on social media, where the language used is often inaccurate and, at times, misleading. The term “GLP-1s” has become a catch-all, when in reality these medications sit within a broader group of incretin-based gut hormone therapies. These therapies act on pathways involving glucagon-like peptide-1 […]